Meridian Bioscience (VIVO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $3.87 -4.91%
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Morgan Stanley upgrades Robinhood, sees 43% upside
- S&P Global completes acquisition of datacenterHawk
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
